A recent review argues that chemical and physical stresses should be considered a normal attribute of the host symbiotic milieu.
Gut Microbiota Research & Practice is a section dedicated to promoting knowledge-sharing and debate among researchers, scientists and healthcare professionals. You will find a selection of discussions about articles from scientific literature as well as other content including interviews with experts, event reports, and special publications.
A recent study, led by Dr. Claire Steves, a clinical research fellow from the Department of Twin Research & Genetic Epidemiology, King’s College London, identified several associations between host frailty and gut microbiota diversity, which might offer potential targets for intervention to strengthen healthy ageing.
A recent study, led by Prof. Andrew Macpherson from the University of Bern (Switzerland), has found in mice that maternal microbiota and immunity strengthen the immune system of the newborn.
Gut microbiota and the ‘inflammatory loop’ in IBD: Interview with Prof. Harry Sokol
16 May 2016by Kristina Campbell
Understandings of inflammatory bowel disease (IBD) have advanced in recent years, informed by studies that have investigated the role of the gut microbiota in disease pathogenesis and progression. Prof. Harry Sokol is a gastroenterologist and researcher from France who has participated in this pioneering work. At the Gut Microbiota for Health World Summit 2016 in Miami, Sokol took the time to speak with GMFH editors.
Severe immunodeficiency in HIV infection is linked to changes in the gut virome and bacterial microbiome
13 May 2016by Kristina Campbell
Human immunodeficiency virus (HIV) infection is a significant global health threat, with an estimated 35 million HIV-positive adults worldwide.
The role of ‘our second genome’ in xenobiotic metabolism and therapeutic outcomes
11 May 2016by Andreu Prados
A recent review, led by Prof. Peter Turnbaugh from the Department of Microbiology & Immunology at University of California San Francisco (USA), discusses several mechanisms that link the gut microbiota with xenobiotic metabolism, and explores how this knowledge can be applied to improve the treatment of human disease.
Conserving and restoring the human gut microbiome by increasing consumption of dietary fibre
9 May 2016by Andreu Prados
Recent research in this area suggests that dietary fibre recommendations should be refigured in future.
A recent study, led by Dr. Josef Anrather, an associate professor of neuroscience at the Weill Cornell Medical College in New York (USA), has found that the commensal gut microbiota could influence the immune system to decrease the severity of ischemic stroke in mice.
A recent study has found that the anti-atherosclerosis effects of resveratrol (RSV) - a plant-based natural phenolic compound used to fight pathogens such as fungi and bacteria - are related to changes in the gut microbiota of mice.
A recent review, published by assistant professor Suzanne Devkota at Cedars-Sinai Medical Centre in Los Angeles (USA), have shed light on the importance of controlling for external factors in microbiome studies, focusing on medications that could have confounding effects.
